The Impact of 12 Week Retention of Nutrients on Skin and the Perception of Physical Health Status
1 other identifier
interventional
120
1 country
1
Brief Summary
This is a randomized, double-blind, placebo-controlled clinical trial exploring the effects of a 12-week dietary supplement regimen on skin condition and perceived overall health status. The study will involve 120 healthy Chinese adults aged 18 and above with low daily fruit and vegetable intake. Participants will be randomly assigned to one of two groups: one group will take a combination of Nu Skin's Vitamin C \& Green Tea Capsules and Multivitamin \& Mineral Capsules, while the other group will take a matching placebo. The primary goal is to assess if the supplement combination improves skin health after 12 weeks, measured through specialized facial imaging (assessing spots, redness, evenness) and probe measurements (assessing elasticity, moisture, gloss). Secondary goals include evaluating changes in participants' self-perceived health status (via quality of life, fatigue, and digestive health questionnaires), psychological resilience, memory, and exploring a new method for measuring skin carotenoid levels. This study is not intended to verify the approved health functions of the products but to explore the potential combined effects of antioxidant and nutritional supplementation on skin and general well-being.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable healthy-volunteers
Started Nov 2025
Shorter than P25 for not_applicable healthy-volunteers
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 3, 2025
CompletedFirst Submitted
Initial submission to the registry
January 19, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 2, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 2, 2026
CompletedFirst Posted
Study publicly available on registry
February 3, 2026
CompletedFebruary 3, 2026
January 1, 2026
3 months
January 19, 2026
January 26, 2026
Conditions
Outcome Measures
Primary Outcomes (7)
Facial Image Capture VISIA-7
Imaging sessions are conducted at T0 (baseline), T4w (4 weeks), T8w (8 weeks), and T12w (12 weeks)
Skin Elasticity Test Probe Cutometer
Measurements are conducted at T0 (baseline), T4w (4 weeks), T8w (8 weeks), and T12w (12 weeks)
Skin Gloss Measurement Glossmeter
Measurements are conducted at T0 (baseline), T4w (4 weeks), T8w (8 weeks), and T12w (12 weeks).
Skin Moisture Content Corneometer
Measurements are conducted at T0 (baseline), T4w (4 weeks), T8w (8 weeks), and T12w (12 weeks)
Skin Hemoglobin Measurement Mexameter MX18 (Courage & Khazaka, Germany)
Measurements are conducted at T0 (baseline), T4w (4 weeks), T8w (8 weeks), and T12w (12 weeks).
Skin Moisture Loss Meter Vapometer (Delfin, Finland)
Measurements are conducted at T0 (baseline), T4w (4 weeks), T8w (8 weeks), and T12w (12 weeks).
Skin Carotenoid Index
Measurements are conducted at T0 (baseline), T4w (4 weeks), T8w (8 weeks), and T12w (12 weeks).
Secondary Outcomes (5)
Skin Condition Survey
The scales and questionnaires are administered at T0 (baseline), T4w (4 weeks), T8w (8 weeks), and T12w (12 weeks).
Physical Health and Life Status Survey
The survey is administered at T0 (baseline), T4w (4 weeks), T8w (8 weeks), and T12w (12 weeks).
Psychological State and Memory Level
The assessment is conducted at T0 (baseline), T4w (4 weeks), T8w (8 weeks), and T12w (12 weeks).
Self-Evaluation Questionnaire
This questionnaire is administered only at follow-up visits: T4w (4 weeks), T8w (8 weeks), and T12w (12 weeks).
Height and Weight Measurement BMI
Measurements are conducted at T0 (baseline, upon enrollment) and T12w (12 weeks).
Study Arms (2)
Supplement Combination Group
EXPERIMENTALPlacebo Control Group
PLACEBO COMPARATORInterventions
Participants take a matching placebo combination (identical in appearance and taste to the active supplements) orally twice daily
Participants take a combination of active supplements-specifically, Vitamin C \& Green Tea Capsules and Multivitamin \& Mineral Capsules-orally twice daily.
Eligibility Criteria
You may qualify if:
- Chinese adults of Asian descent aged 18 and above;
- Daily fruit and vegetable intake \< 240g (calculated based on the fruit and vegetable section of the food frequency questionnaire);
- S3 measurement index \< 30000;
- Participants must possess basic Chinese reading comprehension and expression skills, and be able to independently complete questionnaire surveys;
- Voluntary participation in the test and signing of the informed consent form;
- Willingness to comply with all evaluation requirements.
You may not qualify if:
- Presence of open facial skin lesions, clearly visible scars, acne marks, etc.;
- Skin lesions, scars, or significant pigmentation on the hand measurement area;
- Symptoms of skin disease on the face or hand measurement areas;
- Having undergone medical aesthetic procedures within the last 6 months;
- Participation in other clinical trials involving product use within the last 3 months;
- Use of health supplements or nutritional supplements (e.g., vitamins, minerals) within the last 1 month;
- Currently planning for pregnancy, pregnant, or lactating;
- Presence of any disease under current treatment;
- Any other health issues or chronic diseases that affect behavioral or cognitive abilities;
- Other iatrogenic reasons identified by experts or professionals that may affect the evaluation results.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- ChinaNormlead
Study Sites (1)
Shanghai China-norm Quality Technical Service Co., Ltd.
Shanghai, Shanghai Municipality, 200072, China
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 19, 2026
First Posted
February 3, 2026
Study Start
November 3, 2025
Primary Completion
February 2, 2026
Study Completion
February 2, 2026
Last Updated
February 3, 2026
Record last verified: 2026-01